Bio Lexis Pte Ltd. Outlook Therapeutics, Inc. (OTLK) insider trading activity

OTLK Quotes by TradingView

Bio Lexis Pte Ltd. is > 10% Shareholder of Outlook Therapeutics, Inc.. Currently has a direct ownership of 23 Million shares of OTLK, which is worth approximately $123 Million. The most recent transaction as insider was on Apr 21, 2022, when has been sold 27,982,529 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23M
0% 3M change
0% 12M change
Total Value Held $123 Million

BioLexis Pte Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2022
SELL
Other acquisition or disposition
-
27,982,529 Reduced 54.91%
22,982,529 Common Stock
BPL

Bio Lexis Pte Ltd.

> 10% Shareholder
Singapore, U0

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK